These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33098770)

  • 101. Defects in nerve conduction velocity and different muscle fibre-type specificity contribute to muscle weakness in Ts1Cje Down syndrome mouse model.
    Bala U; Leong MP; Lim CL; Shahar HK; Othman F; Lai MI; Law ZK; Ramli K; Htwe O; Ling KH; Cheah PS
    PLoS One; 2018; 13(5):e0197711. PubMed ID: 29795634
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Down syndrome is an oxidative phosphorylation disorder.
    Bayona-Bafaluy MP; Garrido-Pérez N; Meade P; Iglesias E; Jiménez-Salvador I; Montoya J; Martínez-Cué C; Ruiz-Pesini E
    Redox Biol; 2021 May; 41():101871. PubMed ID: 33540295
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology.
    Barwe SP; Sidhu I; Kolb EA; Gopalakrishnapillai A
    Mol Ther Methods Clin Dev; 2020 Dec; 19():201-209. PubMed ID: 33102613
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Down Syndrome Critical Region 1 Reduces Oxidative Stress-Induced Retinal Ganglion Cells Apoptosis via CREB-Bcl-2 Pathway.
    Shi Y; Ye D; Huang R; Xu Y; Lu P; Chen H; Huang J
    Invest Ophthalmol Vis Sci; 2020 Oct; 61(12):23. PubMed ID: 33104163
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Intellectual disability: dendritic anomalies and emerging genetic perspectives.
    Quach TT; Stratton HJ; Khanna R; Kolattukudy PE; Honnorat J; Meyer K; Duchemin AM
    Acta Neuropathol; 2021 Feb; 141(2):139-158. PubMed ID: 33226471
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Correction: A randomized controlled trial of an online health tool about Down syndrome.
    Chung J; Donelan K; Macklin EA; Schwartz A; Elsharkawi I; Torres A; Hsieh YG; Parker H; Lorenz S; Patsiogiannis V; Santoro SL; Wylie M; Clarke L; Estey G; Baker S; Bauer PE; Bull M; Chicoine B; Cullen S; Frey-Vogel A; Gallagher M; Hasan R; Lamb A; Majewski L; Mast J; Riddell T; Sepucha K; Skavlem M; Skotko BG
    Genet Med; 2021 Jan; 23(1):236. PubMed ID: 33169000
    [No Abstract]   [Full Text] [Related]  

  • 107. DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature.
    Meissner LE; Macnamara EF; D'Souza P; Yang J; Vezina G; ; Ferreira CR; Zein WM; Tifft CJ; Adams DR
    Mol Genet Genomic Med; 2020 Dec; 8(12):e1544. PubMed ID: 33159716
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Mitochondrial DNA copy number in human disease: the more the better?
    Filograna R; Mennuni M; Alsina D; Larsson NG
    FEBS Lett; 2021 Apr; 595(8):976-1002. PubMed ID: 33314045
    [TBL] [Abstract][Full Text] [Related]  

  • 109. OGA Inhibition Alters Energetics and Nutrient Sensing in Alzheimer's Disease Cytoplasmic Hybrids.
    Flax J; Wilkins HM; Miller R; Griffith S; Cork GK; Qiang A; Thompson J; Swerdlow RH; Slawson C
    J Alzheimers Dis; 2020; 78(4):1743-1753. PubMed ID: 33285636
    [TBL] [Abstract][Full Text] [Related]  

  • 110. A Mitochondrial DNA Variant Elevates the Risk of Gallstone Disease by Altering Mitochondrial Function.
    Sun D; Niu Z; Zheng HX; Wu F; Jiang L; Han TQ; Wei Y; Wang J; Jin L
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):1211-1226.e15. PubMed ID: 33279689
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome.
    Adams AD; Hoffmann V; Koehly L; Guedj F; Bianchi DW
    Am J Obstet Gynecol; 2021 Sep; 225(3):296.e1-296.e13. PubMed ID: 33766516
    [TBL] [Abstract][Full Text] [Related]  

  • 112. From the lab to the people: major challenges in the biological treatment of Down syndrome.
    Rondal JA
    AIMS Neurosci; 2021; 8(2):284-294. PubMed ID: 33709029
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The Role of Oxidative Stress in Trisomy 21 Phenotype.
    Buczyńska A; Sidorkiewicz I; Krętowski AJ; Zbucka-Krętowska M
    Cell Mol Neurobiol; 2023 Nov; 43(8):3943-3963. PubMed ID: 37819608
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition.
    Galbraith MD; Rachubinski AL; Smith KP; Araya P; Waugh KA; Enriquez-Estrada B; Worek K; Granrath RE; Kinning KT; Paul Eduthan N; Ludwig MP; Hsieh EWY; Sullivan KD; Espinosa JM
    Sci Adv; 2023 Jun; 9(26):eadg6218. PubMed ID: 37379383
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model.
    Waugh KA; Minter R; Baxter J; Chi C; Galbraith MD; Tuttle KD; Eduthan NP; Kinning KT; Andrysik Z; Araya P; Dougherty H; Dunn LN; Ludwig M; Schade KA; Tracy D; Smith KP; Granrath RE; Busquet N; Khanal S; Anderson RD; Cox LL; Estrada BE; Rachubinski AL; Lyford HR; Britton EC; Fantauzzo KA; Orlicky DJ; Matsuda JL; Song K; Cox TC; Sullivan KD; Espinosa JM
    Nat Genet; 2023 Jun; 55(6):1034-1047. PubMed ID: 37277650
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment.
    Shichiri M; Suzuki H; Isegawa Y; Tamai H
    J Clin Biochem Nutr; 2023 Jan; 72(1):13-22. PubMed ID: 36777080
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Visual discrimination and inhibitory control deficits in mouse models of Down syndrome: A pilot study using rodent touchscreen technology.
    Siegel AE; Bianchi DW; Guedj F
    J Neurosci Res; 2023 Apr; 101(4):492-507. PubMed ID: 36602162
    [TBL] [Abstract][Full Text] [Related]  

  • 118. IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome.
    Araya P; Kinning KT; Coughlan C; Smith KP; Granrath RE; Enriquez-Estrada BA; Worek K; Sullivan KD; Rachubinski AL; Wolter-Warmerdam K; Hickey F; Galbraith MD; Potter H; Espinosa JM
    Cell Rep; 2022 Dec; 41(13):111883. PubMed ID: 36577365
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Studies on Apigenin and Its Biological and Pharmacological Activity in Brain Disorders.
    Kumar V; Kundu S
    Adv Pharm Bull; 2022 Aug; 12(4):645-648. PubMed ID: 36415642
    [No Abstract]   [Full Text] [Related]  

  • 120. The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives.
    Stagni F; Bartesaghi R
    Front Cell Neurosci; 2022; 16():903729. PubMed ID: 35634470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.